SANTA MONICA, Calif. (PRWEB)
February 28, 2023

StudyKIK, a leading provider of clinical trial technologies, was twice awarded for products making a positive impact in the clinical research industry at the 2023 Summit for Clinical Ops Executives (SCOPE), a conference focused on advancing innovative solutions in all aspects of clinical trial innovation and management.

StudyKIK’s Oncology Study App was awarded the Participation Engagement Award, an accolade recognizing innovation and change in how the clinical research industry communicates with participants in the fields of recruitment and retention in clinical trials. The mobile application, rooted in feedback from real patients who have participated in complex trials, focuses on making clinical trials easier and more accessible for patients and their support networks.

More than 3,000 attendees voted on best new products in the clinical trial and research space and selected StudyCash, StudyKIK’s new patient payment platform, as a recipient of the Best of Show Award. The award identifies exceptional innovation in technologies used by life science professionals, voting on the most impactful new products of the year. StudyCash provides a convenient and secure system for clinical trial participants across the globe to request payment for their study related activities and expenses, from the ease of their mobile device.

“It’s an incredible feeling to have our hard work and dedication recognized at SCOPE 2023,” said Greg Christie, Chief Product Officer of StudyKIK. “We couldn’t be more thrilled that StudyKIK’s passion for excellence and our drive to make a real difference in the industry was acknowledged with not one, but two awards. Receiving the Participant Engagement Award for our oncology app and Best in Show for StudyCash, our new patient payment solution, is validation of our mission to transform the study experience with innovative, empathetic and thoughtful technology.”

StudyKIK’s advancements highlight how technology acts as a tool to keep patients connected and engaged to the clinical trial lifecycle while breaking barriers to increase accessibility, for greater inclusivity in research studies. In 2021, the company was acquired by Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, to expand access to its solutions to a broader network of sites and sponsors to accelerate clinical trial recruitment, retention and diversity.

About StudyKIK

StudyKIK is a leader in clinical trial management technologies with solutions focused on patient recruitment and retention. Founded in 2014, StudyKIK aims to improve and streamline the clinical trial lifecycle to offer a better experience for patients, sites, and sponsors through technologies that are interconnected. With a mission to make a difference in the world by bringing new treatments to people faster through education and innovative technology, StudyKIK continues to develop new technology-enabled, insight-powered solutions to help support clinical research. For more information visit http://www.studykik.com.

About Syneos Health

Syneos Health® (Nasdaq:SYNH) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.

We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics.

Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.

Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.

Share article on social media or email: